Overview
The Dr. Edward T. Rancic Memorial Fund provides support for a post-doctoral fellowship focused on renal cell cancer—the most common form of kidney cancer in the laboratory of Richard Childs, M.D., Director of the National Heart, Lung, and Blood Institute (NHLBI) Division of Intramural Research (DIR). The goal of this fund is to provide critical personnel support to accelerate the search for new breakthroughs in the treatment of kidney cancer with additional significant contributions received from individual donors. This fund is complementary to and in concert with the Dean R. O’Neill Renal Cell Cancer Research Fund and the Boo! Run for Life event. Founded in 2004 by the Rancic family, the Dr. Edward T. Rancic Memorial Fund for Cancer Research at the FNIH supports a Post-Baccalaureate Fellow in the laboratory of Dr. Richard Childs at the National Heart, Lung, and Blood Institute (NHLBI) to search for a cure for renal cell carcinoma. Commonly referred to as kidney cancer, renal cell carcinoma is an under-researched and growing disease that is diagnosed in more than 50,000 individuals each year.
Partners
Public-Sector Partners:
- National Heart, Lung, and Blood Institute (NHLBI)
Private-Sector Partners:
- Family of Edward T. Rancic*
*Provided financial or in-kind support for this program.
FNIH Contacts
- Advancement Office, [email protected] or 301-402-4976
With the support of the Rancic Fund, the Fellow in Dr. Childs’ lab explores treatments such as allogeneic stem cell transplantation, chemotherapy, radiation therapy, immunotherapy, vaccine therapy and drug treatments.
This fund is complementary to and in concert with the Dean R. O’Neill Renal Cell Cancer Research Fund and the annual Boo! Run for Life 10K Run and Tidal Basin Walk, and is supported by generous contributions from individuals.
Read the Department of Health & Human Services’ Post-Baccalaureate Student Progress Report (July 16, 2015) here.
Goals
- Support a Fellow in Dr. Richard Childs’ laboratory to explore treatments such as allogeneic stem cell transplantation, chemotherapy, radiation therapy, immunotherapy, vaccine therapy and drug treatments.